Doctor profile · Federal record
Dr. Antonio Fontelonga
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Reno, NV
- NPI 1437164100
- Accepts Medicare
- 50 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
75 Pringle Way Ste 706
Reno, NV 895021472
(775) 784-5975
fax (775) 784-3722
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- November 6, 2014
- Year of graduation
- 1976 — 50 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Nevada #100667
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437164100. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,199
Distinct HCPCS
10
Medicare allowed
$96,137
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 892 | 16 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 832 | 12 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 356 | 163 | $123 | |
96375 |
Injection of additional new drug or substance into vein | 267 | 24 | $15 | |
96372 |
Injection of drug or substance under skin or into muscle | 166 | 25 | $14 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 138 | 21 | $125 | |
36415 |
Insertion of needle into vein for collection of blood sample | 135 | 70 | $8 | |
96523 |
Irrigation of implanted venous access drug delivery device | 129 | 25 | $24 | |
J1200 |
Injection, diphenhydramine hcl, up to 50 mg | 105 | 20 | $1 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 77 | 42 | $171 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 1,102. This provider delivers 2.9× the peer median.Open Payments
Industry payments received
All-time total
$1,446
Transactions
57
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $242.59 | |
| AstraZeneca Pharmaceuticals LP | 8 | $215.72 | |
| GlaxoSmithKline, LLC. | 11 | $191.77 | |
| Janssen Biotech, Inc. | 4 | $151.06 | |
| Incyte Corporation | 4 | $146.47 | |
| Aveo Pharmaceuticals, Inc. | 3 | $121.03 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54.16 | |
| BeiGene USA, Inc. | 2 | $43.44 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41.77 | |
| Alexion Pharmaceuticals, Inc. | 2 | $41.24 | |
| Lilly USA, LLC | 2 | $31.62 | |
| Janssen Pharmaceuticals, Inc | 1 | $22.00 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21.92 | |
| PUMA BIOTECHNOLOGY, INC. | 1 | $21.78 | |
| Gilead Sciences, Inc. | 1 | $20.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
115
Patients
19
Total drug cost
$23,489
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 45 | 19 | $1,253 |
| Hydroxyurea | Generic | 19 | 0 | $590 |
| Ondansetron Hcl | Generic | 16 | 0 | $164 |
| Abiraterone Acetate | Generic | 12 | 0 | $20,632 |
| Alendronate Sodium | Generic | 12 | 0 | $250 |
| Letrozole | Generic | 11 | 0 | $598 |
Hospital affiliations
Frequently asked questions
What is Dr. Antonio Fontelonga's medical specialty?
Dr. Antonio Fontelonga practices Hematology & Oncology Physician in Reno, NV.
Where does Dr. Antonio Fontelonga practice?
Dr. Antonio Fontelonga practices at 75 Pringle Way Ste 706, Reno, NV 895021472. Office phone: 7757845975.
What is Dr. Antonio Fontelonga's NPI?
Dr. Antonio Fontelonga's National Provider Identifier (NPI) is 1437164100, issued by NPPES.
Does Dr. Antonio Fontelonga accept Medicare assignment?
Yes. Dr. Antonio Fontelonga accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Antonio Fontelonga commonly perform?
Top Medicare-reported procedures in 2023: Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Injection, ondansetron hydrochloride, per 1 mg (HCPCS J2405); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.